Princeton Acquisitions Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
Article By: Lorimer Wilson
Monday, March 4, 2024 12:41 AM EDT
Grand View Research says the global "AI in drug discovery" market should expand at a CAGR of 30% between now, and 2030 which Morgan Stanley believes will lead to 50 novel therapies over the next decade, with annual sales in excess of $50 billion.
In this article: EXAI, SDGR, ABCL, BTAI, RLAY, LTRN, ABSI, RXRX
Read
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
Article By: Lorimer Wilson
Monday, February 19, 2024 12:05 AM EDT
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway. 
In this article: EXAI, SDGR, ABCL, BTAI, RLAY, LTRN, ABSI, RXRX
Read
AI-Focused Drug Discovery Stocks Index Up 26% In December
Article By: Lorimer Wilson
Friday, December 29, 2023 11:49 AM EDT
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.
In this article: EXAI, SDGR, ABCL, BTAI, RLAY, LTRN, ABSI, RXRX
Read
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
Article By: Lorimer Wilson
Sunday, December 17, 2023 11:20 PM EDT
A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.
In this article: EXAI, SDGR, ABCL, BTAI, RLAY, LTRN, ABSI, RXRX
Read
The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week
Article By: Lorimer Wilson
Monday, December 11, 2023 1:14 AM EDT
If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to streamline drug discovery and development.
In this article: EXAI, SDGR, ABCL, RLAY, ABSI, RXRX
Read
All Posts

Latest Tweets for $SDGR

No tweets yet!

PARTNER HEADLINES